Nippon India Small Cap Fund
Indoco Remedies Limited · NSE
25,94,559 sh · ₹56.95 Cr
Nippon India Small Cap Fund
0.1% of their portfolio
₹56.95 Cr
25,94,559 sh
Nippon India Pharma Fund
0.4% of their portfolio
₹40.27 Cr
18,34,924 sh
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
0.5% of their portfolio
₹36.48 Cr
16,62,047 sh
HDFC Value Fund
42.0% of their portfolio
₹33.68 Cr
15,34,403 sh
Kare Family Private Trust
Investor
₹1.11 Cr
1,30,97,055 sh
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Nippon India Small Cap Fund
Indoco Remedies Limited · NSE
25,94,559 sh · ₹56.95 Cr
HDFC Value Fund
Indoco Remedies Limited · NSE
15,34,403 sh · ₹33.68 Cr
Nippon India Pharma Fund
Indoco Remedies Limited · NSE
18,34,924 sh · ₹40.27 Cr
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Indoco Remedies Limited · NSE
16,62,047 sh · ₹36.48 Cr
Nippon India Small Cap Fund
Indoco Remedies Limited · NSE
25,94,559 sh · ₹62.07 Cr
Nippon India Pharma Fund
Indoco Remedies Limited · NSE
18,34,924 sh · ₹43.90 Cr
HDFC Value Fund
Indoco Remedies Limited · NSE
15,34,403 sh · ₹36.71 Cr
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Indoco Remedies Limited · NSE
16,62,047 sh · ₹39.76 Cr
HDFC Value Fund
Indoco Remedies Limited · NSE
15,34,403 sh · ₹32.17 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
24 announcements on record for this company.
Promoter holding by quarter: Jun 2025 58.9%, Sep 2025 58.9%, Dec 2025 58.9%, Mar 2026 58.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.2pp
FII holding by quarter: Jun 2025 1.2%, Sep 2025 1.3%, Dec 2025 1.1%, Mar 2026 0.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 19.0%, Sep 2025 18.2%, Dec 2025 18.1%, Mar 2026 18.1%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 18.6%, Sep 2025 17.6%, Dec 2025 17.6%, Mar 2026 17.5%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Nippon India Small Cap Fund
Indoco Remedies Limited · NSE
25,94,559 sh · ₹54.40 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 58.9%, Sep 2025 58.9%, Dec 2025 58.9%, Mar 2026 58.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
FII
— −0.2pp
FII holding by quarter: Jun 2025 1.2%, Sep 2025 1.3%, Dec 2025 1.1%, Mar 2026 0.9%. Sep 2024, Dec 2024, Mar 2025: no filing.
DII
— 0.0pp
DII holding by quarter: Jun 2025 19.0%, Sep 2025 18.2%, Dec 2025 18.1%, Mar 2026 18.1%. Sep 2024, Dec 2024, Mar 2025: no filing.
MF
— 0.0pp
MF holding by quarter: Jun 2025 18.6%, Sep 2025 17.6%, Dec 2025 17.6%, Mar 2026 17.5%. Sep 2024, Dec 2024, Mar 2025: no filing.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
24 announcements on record for this company.